
Home » Pipeline
Pipeline
Company | Drug/Device | Medical Condition | Status |
---|---|---|---|
Bio-Thera Solutions | BAT4306F | CD-20-positive B-cell non-Hodgkins lymphoma | Phase I trial initiated |
Alligator Bioscience | ATOR-1015 | advanced solid tumor disease | Phase I trial initiated enrolling up to 53 subjects at five clinics in Sweden and Denmark |
Rodin Therapeutics | RDN-929 | snyaptopathies, a group of over 100 brain diseases characterized by synaptic loss and disfunction | Phase I trial initiated |
Protagonist Therapeutics, Inc. | PN-10943 | inflammatory bowel disease | Phase I trial initiated |
Aridis Pharmaceuticals | AR-501 (gallium citrate) | chronic bacterial lung infections in patients with Cystic Fibrosis | Phase I/II trial initiated enrolling 96 (48 healthy and 48 with Cystic Fibrosis) subjects |
Constellation Pharmaceuticals, Inc. | CPI-1205 | metsastic castration-resistant prostate cancer (mCRPC) | Phase II trial initiated enrolling up to 35 subjects |
KaNDy Therapeutics | NT-814 | troublesome post-menopausal symptoms, including hot flashes | Phase II trial initiated enrolling up to 165 menopausal subjects aged 40 to 65 years |
Levo Therapeutics, Inc. | intranasal carbetocin (LV-101) | Prader-Willi syndrome (PWS) | Phase III trial initiated |
Generex Biotechnology Corporation | AE37 plus Keytruda (pembrolizumab) | triple negative breast cancer | IND clearance granted by the FDA |
Virtus Pharmaceuticals, LLC | generic Levorphanol Tartrate 2 mg tablets | severe pain | ANDA approval granted by the FDA |
Asana Biosciences | Janus Kinase (JAK) and Spleen Tyrosine Kinase (SYK) dual inhibitor ASN002 | moderate-to-severe atopic dermatitis | Fast Track Designation granted by the FDA |
Gibson Oncology, LLC | LMP-400 small molecule topoisomerase 1inhibitor | Ewing sarcoma | Rare Pediatric Disease Designation (RPDD) granted by the FDA |
Sandoz, Inc. and Pear Therapeutics, Inc. | reSET-O | Opioid Use Disorder (OUD) | Clearance granted by the FDA |
Planmed Oy | new features and intended uses of Planmed Verity orthopedic imaging solution | reconstructive surgeries | Approval granted by the FDA |
Genentech | Tecentriq and Avastin | metastatic non-squamous non-small cell lung cancer (NSCLC) | Approval granted by the FDA |
Mayne Pharma Group Limited | Tolsura (SUBA-itraconazole) | systemic fungal infections | Approval granted by the FDA |
Upcoming Events
-
05Dec
-
14Apr